David Nierengarten

David Nierengarten has extensive work experience in the finance and biotechnology industries. David started their career at Research Corporation Technologies, where they worked as an Analyst, sourcing deals and conducting due diligence on early-stage biotech ventures. David then moved on to RW Baird &Co, where they served as a Research Associate. After that, they joined Epiphany Bioscience as the Director of Business Development, responsible for developing partnerships and driving business growth. Currently, they hold the position of Managing Director at Wedbush Securities. Overall, David has a strong background in financial analysis, deal sourcing, and business development within the biotech sector.

David Nierengarten's education history includes obtaining a B.S. in Biochemistry from the University of Wisconsin-Madison from 1993 to 1997. David then pursued further studies in Biochemistry, earning a PhD from the University of California, Berkeley from 1997 to 2003. Prior to their undergraduate studies, they attended St. Thomas More High School from 1989 to 1993. The degree obtained from high school is not specified.